Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Search Result
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Apply
Camizestrant
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step